News Daily News German COVID-19 Autopsy Data Show Thromboembolism, ‘Heavy’ Lungs L.A. McKeown May 11, 2020
News Daily News Like Tobacco, Long-term E-Cigarettes Harm Vascular Function Caitlin E. Cox April 30, 2020
News Daily News Smartphones Aid in Remote Monitoring of Patients With Recent Acute MI L.A. McKeown April 21, 2020
News Daily News Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers Michael O'Riordan April 15, 2020
News Daily News Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns Shelley Wood April 13, 2020
News Conference News ACC 2020 New Patient-Focused TAVR Quality Score Rolling Out to US Hospitals Michael O'Riordan April 06, 2020
News Conference News ACC 2020 Lower Risk of Death With Conscious Sedation in TAVR: TVT Registry Michael O'Riordan March 19, 2020
News Opinion Editor's Corner COVID-19 and the Heart: Insights From the Front Lines Shelley Wood March 12, 2020
News Opinion Off Script COVID-19 Begs the Question: If Medical Meetings Go Virtual, What Do We Gain and Lose? Asif Qasim, MB BChir, PhD March 06, 2020
News Daily News CRT 2020 Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease Michael O'Riordan March 04, 2020
News Features Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology Michael O'Riordan March 03, 2020
News Daily News New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib Shelley Wood February 28, 2020
News Conference News CRT 2020 Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR L.A. McKeown February 24, 2020
News Daily News Gender Gaps Persist in CV Research, Editorships, and Training Yael L. Maxwell February 20, 2020
News Daily News PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching Shelley Wood February 19, 2020
News Daily News FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns Shelley Wood February 14, 2020
News Daily News SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE Michael O'Riordan February 03, 2020